LEQSELVI Trademark

Trademark Overview


On Friday, February 23, 2024, a trademark application was filed for LEQSELVI with the United States Patent and Trademark Office. The USPTO has given the LEQSELVI trademark a serial number of 98418436. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 22, 2024. This trademark is owned by Sun Pharmaceutical Industries, Inc.. The LEQSELVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
leqselvi

General Information


Serial Number98418436
Word MarkLEQSELVI
Filing DateFriday, February 23, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 22, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized word LEQSELVI in gradiant blue.
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSun Pharmaceutical Industries, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Party NameSun Pharmaceutical Industries, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events


Event DateEvent Description
Friday, February 23, 2024NEW APPLICATION ENTERED
Sunday, June 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 12, 2024ASSIGNED TO EXAMINER
Monday, September 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED